Adiponectin, an adipocyte-derived protein

被引:130
作者
Nedvídková, J [1 ]
Smitka, K [1 ]
Kopsky, V [1 ]
Hainer, V [1 ]
机构
[1] Inst Endocrinol, Narodni 8, Prague 11694 1, Czech Republic
关键词
adiponectin; adipose tissue; energy metabolism; animal and human studies;
D O I
10.33549/physiolres.930600
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Adipose tissue is a hormonally active tissue, producing adipocytokines which may influence activity of other tissues. Adiponectin, abundantly present in the plasma increases insulin sensitivity by stimulating fatty acid oxidation, decreases plasma triglycerides and improves glucose metabolism. Adiponectin levels are inversely related to the degree of adiposity. Anorexia nervosa and type I diabetes are associated with increased plasma adiponectin levels and higher insulin sensitivity. Decreased plasma adiponectin levels were reported in insulin-resistant states, such as obesity and type 2 diabetes and in patients with coronary artery disease. Activity of adiponectin is associated with leptin, resistin and with steroid and thyroid hormones, glucocorticoids, NO and others. Adiponectin suppresses expression of extracellular matrix adhesive proteins in endothelial cells and atherosclerosis potentiating cytokines. Anti-atherogenic and anti-inflammatory properties of adiponectin and the ability to stimulate insulin sensitivity have made adiponectin an important object for physiological and pathophysiological studies with the aim of potential therapeutic applications.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 48 条
[1]   Decreased plasma adiponectin concentration in patients with essential hypertension [J].
Adamczak, M ;
Wiecek, A ;
Funahashi, T ;
Chudek, J ;
Kokot, F ;
Matsuzawa, Y .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (01) :72-75
[2]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]  
Berk E, 2003, OBES RES, V11, pA34
[4]   Adiponectin stimulates production of nitric oxide in vascular endothelial cells [J].
Chen, H ;
Montagnani, M ;
Funahashi, T ;
Shimomura, I ;
Quon, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :45021-45026
[5]   Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR [J].
Chinetti, G ;
Zawadski, C ;
Fruchart, JC ;
Staels, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (01) :151-158
[6]  
Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662
[7]   Pre- and post-translational negative effect of β-adrenoceptor agonists on adiponectin secretion:: in vitro and in vivo studies [J].
Delporte, ML ;
Funahashi, T ;
Takahashi, M ;
Matsuzawa, Y ;
Brichard, SM .
BIOCHEMICAL JOURNAL, 2002, 367 (03) :677-685
[8]   The role of the novel adipocyte-derived hormone adiponectin in human disease [J].
Díez, JJ ;
Iglesias, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (03) :293-300
[9]   Isoproterenol is a positive regulator of the suppressor of cytokine signaling-3 gene expression in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Klein, J ;
Lossner, U ;
Paschke, R .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (03) :727-733
[10]   Negative regulation of adipose-expressed galectin-12 by isoproterenol, tumor necrosis factor α, insulin and dexamethasone [J].
Fasshauer, M ;
Klein, J ;
Lossner, U ;
Paschke, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (04) :553-559